What Can We Help You Find?

Dr. Raymond U. Osarogiagbon, MD
Chief Scientist for Baptist Memorial Health Care, Director of Baptist Cancer Center’s Multidisciplinary Thoracic Oncology Program and Thoracic Oncology Research Group, and Principal Investigator of Baptist’s Mid-South Minority-Underserved Consortium initiative, NCORP, in Memphis, Tennessee.

Dr. Osarogiagbon is a practicing thoracic medical oncologist, cancer care delivery researcher and administrator at the Baptist Cancer Center, a Research Professor at Vanderbilt University, and a Research Member of the Vanderbilt Ingram Cancer Center.

Active Funded Projects

Principal Investigator and Director of the ‘Mid-South Miracle’. 2021 to 2030.

The Baptist Memorial Healthcare Corporation’s operationally-funded 10-year commitment to reduce lung cancer mortality within a 107-county service area population by a 25% greater rate than the aggregate US average, by disseminating seven specific programs: tobacco control, early detection through screening and incidental lung nodule programs, multidisciplinary decision-making, surgical quality improvement, pathology quality improvement and dissemination of clinical trials access.

PI: 2UG1CA189873-06. 08/01/19 – 07/31/25. NCI

‘Baptist Health System/ Mid-South NCORP Minority Underserved Consortium.’ This is a competitive 6-year renewal of 1UG1CA189873, enabling the Baptist Memorial Health Care Corporation to build out Research infrastructure throughout the catchment area population in Arkansas, Mississippi and Tennessee.

MPI (with Deborah Schrag, Sandra Wong and Michael Hassett): 1UM1CA233080-01. 09/01/18 – 08/31/2023. NCI

‘SIMPRO Research Center: Integration and Implementation of PROs for Symptom Management in Oncology Practice.’ This grant support development and prospective testing of electronic patient-reported outcomes systems into the Electronic Health Record of patients with early and advanced malignancies undergoing curative-intent and palliative treatment.

PI: 2R01CA172253. NCI. Osarogiagbon (PI). 07/01/18 – 06/30/23

‘Improving pathologic nodal staging of resected lung cancer.’ The goal of this study is to improve the gross dissection of resected lung specimens after curative-intent resection of lung cancer in conjunction with an invented lymph node specimen collection kit intervention to improve intraoperative surgical nodal harvest.